The introduction of new and less expensive IGS systems for ENT procedures will result in a steady unit sales growth rate over the forecast period. Towards the end of the forecast period, IGS system sales will begin to increase slightly as the ASP of these systems will decrease. New sales are coming from smaller facilities without an IGS system, facilities that require additional IGS systems, and from those that need to replace older systems.
In 2016, IGS was considered the standard of care for the following ENT procedures; functional endoscopic sinus surgery (FESS), revisions and skull-based procedures. As more ENT surgeons become comfortable using IGS systems and the systems increase in their simplicity, surgeons will use IGS for a higher percentage of all types of procedures. The number of ENT procedures performed in the U.S. is expected to increase over the forecast period and, as the ENT IGS market approaches saturation, sales growth will follow suit.
Key Topics Covered:
1. Executive Summary
U.S. Surgical Navigation And Robotic Systems Market
Key Report Updates
2. Disease Overview
2.1 Medical Conditions
2.1.1 Neurosurgery Conditions
2.1.2 Spinal Conditions
2.1.3 Ent Conditions
2.1.4 Orthopedic Conditions
2.1.5 Gynecological Conditions
2.1.6 Urological Conditions
2.1.7 Digestive Tract Conditions
2.1.8 Colorectal Conditions
2.1.9 Cardiac Conditions
3. Product Assessment
3.1 Surgical Navigation Product Portfolios
3.1.2 Ear, Nose, Throat Surgery
3.2 Surgical Navigation Regulatory Issues And Recalls
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.